Pembrolizumab in Combination With Decitabine and Hypofractionated Index Lesion Radiation in Pediatrics and Young Adults

NCT03445858 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Childhood Solid Tumor
Childhood Lymphoma
Relapsed Cancer
Refractory Cancer
Adult Solid Tumor
Adult Lymphoma

Interventions

DRUG: Pembrolizumab
DRUG: Decitabine
RADIATION: Hypofractionated Index Site Radiation

Sponsor

Children's Hospital Medical Center, Cincinnati